Scinai Immunotherapeuti Stock Forecast - Naive Prediction
| SCNI Stock | USD 0.76 0 0.38% |
The Naive Prediction forecasted value of Scinai Immunotherapeutics on the next trading day is expected to be 0.40 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.84. Scinai Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Scinai Immunotherapeuti's historical fundamentals, such as revenue growth or operating cash flow patterns.
The Scinai Immunotherapeuti's current Payables Turnover is estimated to increase to 3.46, while Inventory Turnover is projected to decrease to under 62.3 K. . The Scinai Immunotherapeuti's current Common Stock Shares Outstanding is estimated to increase to about 846.7 K, while Net Loss is projected to decrease to (7 M). Scinai Immunotherapeuti Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Scinai Immunotherapeuti's financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2013-12-31 | Previous Quarter 989 K | Current Value 989 K | Quarterly Volatility 6.2 M |
Scinai Immunotherapeuti Naive Prediction Price Forecast For the 25th of December
Given 90 days horizon, the Naive Prediction forecasted value of Scinai Immunotherapeutics on the next trading day is expected to be 0.40 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.84.Please note that although there have been many attempts to predict Scinai Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Scinai Immunotherapeuti's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Scinai Immunotherapeuti Stock Forecast Pattern
| Backtest Scinai Immunotherapeuti | Scinai Immunotherapeuti Price Prediction | Buy or Sell Advice |
Scinai Immunotherapeuti Forecasted Value
In the context of forecasting Scinai Immunotherapeuti's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Scinai Immunotherapeuti's downside and upside margins for the forecasting period are 0.01 and 7.00, respectively. We have considered Scinai Immunotherapeuti's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Scinai Immunotherapeuti stock data series using in forecasting. Note that when a statistical model is used to represent Scinai Immunotherapeuti stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.4612 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0794 |
| MAPE | Mean absolute percentage error | 0.0728 |
| SAE | Sum of the absolute errors | 4.8439 |
Predictive Modules for Scinai Immunotherapeuti
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Scinai Immunotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Scinai Immunotherapeuti
For every potential investor in Scinai, whether a beginner or expert, Scinai Immunotherapeuti's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Scinai Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Scinai. Basic forecasting techniques help filter out the noise by identifying Scinai Immunotherapeuti's price trends.Scinai Immunotherapeuti Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scinai Immunotherapeuti stock to make a market-neutral strategy. Peer analysis of Scinai Immunotherapeuti could also be used in its relative valuation, which is a method of valuing Scinai Immunotherapeuti by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Scinai Immunotherapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Scinai Immunotherapeuti's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Scinai Immunotherapeuti's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Scinai Immunotherapeuti Market Strength Events
Market strength indicators help investors to evaluate how Scinai Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scinai Immunotherapeuti shares will generate the highest return on investment. By undertsting and applying Scinai Immunotherapeuti stock market strength indicators, traders can identify Scinai Immunotherapeutics entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.76 | |||
| Day Typical Price | 0.76 | |||
| Price Action Indicator | 0.0044 | |||
| Period Momentum Indicator | 0.0029 |
Scinai Immunotherapeuti Risk Indicators
The analysis of Scinai Immunotherapeuti's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Scinai Immunotherapeuti's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting scinai stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.97 | |||
| Standard Deviation | 6.6 | |||
| Variance | 43.55 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Historical Fundamental Analysis of Scinai Immunotherapeuti to cross-verify your projections. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Semiconductors & Semiconductor Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scinai Immunotherapeuti. If investors know Scinai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scinai Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.872 | Earnings Share 4 | Quarterly Revenue Growth 0.361 | Return On Assets | Return On Equity |
The market value of Scinai Immunotherapeutics is measured differently than its book value, which is the value of Scinai that is recorded on the company's balance sheet. Investors also form their own opinion of Scinai Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Scinai Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scinai Immunotherapeuti's market value can be influenced by many factors that don't directly affect Scinai Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scinai Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scinai Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scinai Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.